Dergiler / Erciyes Medical Journal / 2016 / Cilt: 38 - Sayı: 4

What Levels of Uric Acid and NT-Probnp Predict Outcomes of Eisenmenger Syndrome in Children?

Sayfa
138–143
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There was no significant difference between serum uric acid level and pulmonary vascular resistance, right atrial pressure, or mean pulmonary arterial pressure.Conclusion: It is too early to determine if serum biomarkers can replace classical diagnostic methods in Eisenmenger syndrome; further studies are required.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Noninvasive methods for follow-up of pulmonary hypertensive children are limited.
📊
Temel Bulgular & Veri:To our best knowledge, this is the first study to investigate the levels of NT-proBNP and uric acid in pediatric Eisenmenger patients.Materials and Methods: Sixteen patients with Eisenmenger syndrome and 37 healthy children as controls were included in the study.
💡
Sonuç & Katkı:There was no significant difference between serum uric acid level and pulmonary vascular resistance, right atrial pressure, or mean pulmonary arterial pressure.Conclusion: It is too early to determine if serum biomarkers can replace classical diagnostic methods in Eisenmenger syndrome; further studies are required.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Noninvasive methods for follow-up of pulmonary hypertensive children are limited. The main aim of this study was to determine the cutoff levels for uric acid and N-terminal pro-brain natriuretic peptide (NT-proBNP) for follow-up of Eisenmenger patients and their relationships with classical methods. To our best knowledge, this is the first study to investigate the levels of NT-proBNP and uric acid in pediatric Eisenmenger patients.Materials and Methods: Sixteen patients with Eisenmenger syndrome and 37 healthy children as controls were included in the study. The serum NT-proBNP and uric acid levels of the participants were measured. The echocardiography, six-minute walk test, and right cardiac catheterization data of the two groups were compared.Results: NT-proBNP>81.4 pg/mL and uric acid >3.5 mg/dL were found to be the most specific and sensitive points for predicting the severity of pulmonary hypertension in Eisenmenger syndrome. There was no significant difference between mean pulmonary arterial pressure and serum NT-proBNP level; however, the differences between pulmonary vascular resistance and serum NT-proBNP level and between mean pulmonary arterial pressure and serum NT-proBNP level were significant. There was no significant difference between NT-proBNP level and New York Heart Association functional classification or six-minute walk test distance. There was no significant difference between serum uric acid level and pulmonary vascular resistance, right atrial pressure, or mean pulmonary arterial pressure.Conclusion: It is too early to determine if serum biomarkers can replace classical diagnostic methods in Eisenmenger syndrome; further studies are required.

🔖

Bu Makaleye Atıf Yap

PAMUKÇU, Ö., YILMAZ, E., NARİN, N., BAYKAN, A., ARGUN, M., ÖZYURT, A., ÜZÜM, K. (2016). What Levels of Uric Acid and NT-Probnp Predict Outcomes of Eisenmenger Syndrome in Children?. Erciyes Medical Journal, Cilt: 38 - Sayı: 4, 138–143. https://ajindex.com/articles/203579

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Kurzyna M, Araszkiewicz A, Blaszczak P, Grabka M, Hawranek M, Kopec G, et al. Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint state- ment of the Polish Cardiac Society's Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions. Kardiol Pol 2015; 73(1): 63-8. [CrossRef] Jardim C, Souza R. Biomarkers and prognostic indicators in pulmo- nary arterial hypertension. Curr Hypertens Rep 2015; 17(6): 556. [CrossRef] Heresi GA. Clinical perspective: biomarkers in pulmonary arterial hy- pertension. Int J Clin Pract Suppl 2011; 169: 5-7. [CrossRef] Siekmeier R, Grammer T, März W. Role of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function. J Cardiovasc Pharmacol Ther 2008; 13(4): 279-97. [CrossRef] Sanli C, Oguz D, Olgunturk R, Tunaoglu FS, Kula S, Pasaoglu H. Elevated homocysteine and asymmetric dimethyl arginine levels in pul- monary hypertension associated with congenital heart disease. Pediatr Cardiol 2012; 33(8): 1323-31. [CrossRef] Takatsuki S, Wagner BD, Ivy DD. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. Congenit Heart Dis 2012; 7(3): 259-67. [CrossRef] Palmieri V, Manganelli F, Russo C, Gagliardi B, Pezzullo S, Gagliar- di G et al. Accuracy and feasibility of simplified Doppler-based left ventricular ejection fraction. Am J Cardiol 2013; 112(6): 889-94. [CrossRef] Maron BA. Hemodynamics should be the primary approach to di- agnosing, following, and managing pulmonary arterial hypertension. Can J Cardiol 2015; 31(4): 515-20. [CrossRef] Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systemat- ic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119(1): 256-70. [CrossRef] Savarese G, Paolillo S, Costanzo P, D'Amore C, Cecere M, Losco T, et al. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials. J Am Coll Cardiol 2012; 60(13): 1192-201. [CrossRef] Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM. Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatr Res 2008; 63(3): 321-7. [CrossRef] Howard LS. Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease. Eur Respir Rev 2011; 20(122): 236-42. [CrossR